British American Tobacco no longer offers compelling long-term growth, prompting a full exit after strong capital gains.
9don MSN
Philip Morris International seeks FDA approval to keep marketing IQOS as reduced risk product
The FDA granted the MRTP designation to the IQOS system in 2020 for an initial four-year period. The evidence presented to ...
Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.
Philip Morris International Inc. (NYSE:PM) manufactures and sells cigarettes and smoke-free products, including IQOS and ZYN ...
Philip Morris's unwavering commitment to income generation reached a new milestone in September 2025 when the company ...
Philip Morris International Inc. (PM) announced that it recently presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC), a panel of independent ...
Philip Morris International (PMI) is redefining its identity from a legacy tobacco company into a forward-thinking provider of next-generation, smoke-free ...
"That change is real... The question is, can we accelerate it? And the answer, in my view, is yes," Di Giovanni said. MANILA, Philippines -- Philip Morris International (PMI) has ...
Philip Morris International Sustainability explores PMI's shift from cigarettes to smoke-free alternatives, delivering ...
Italy's antitrust regulator said on Wednesday it had opened an investigation into Philip Morris Italia for alleged unfair ...
PMI CEO Jacek Olczak shares how science, regulation, and consumer behavior must align to achieve a global smoke-free future.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results